Brief: Xspray Q3 Adjusted EPS SEK -1.59

Xspray Pharma publ AB

08/11/2023 07:02

Nov 8 (Reuters) - Xspray Q3 adjusted free cash flow SEK -68.611 million.
* Q3 pretax profit SEK -38.942 million
* Q3 adjusted EPS SEK -1.59
* Q3 revenue SEK 0